Roche Diagnostics GmbH, Penzberg, Germany.
Biotechnol Prog. 2022 May;38(3):e3244. doi: 10.1002/btpr.3244. Epub 2022 Mar 11.
In the control strategy for process related impurities in biopharmaceuticals, the enzyme linked immunosorbent assay (ELISA) is the method of choice for the quantification of host cell proteins (HCPs). Besides two dimensional-western blots (2D-WB), the coverage of ELISA antibodies is increasingly evaluated by affinity purification-based liquid chromatography-tandem mass spectrometry (AP-MS) methods. However, all these methods face the problem of unspecific binding issues between antibodies and the matrix, involving the application of arbitrarily defined thresholds during data evaluation. To solve this, a new approach (optimized AP-MS) was developed in this study, for which a cleavable linker was conjugated to the ELISA antibodies enabling the subsequent isolation of specifically interacting HCPs. By comparing both approaches in terms of method variability and the number of false positive or negative hits, we could demonstrate that the optimized AP-MS method is very reproducible and superior in the identification of antibody detection gaps, while previously described strategies suffered from over- or underestimating the coverage. As only antibody associated HCPs were identified, we demonstrated that the method is beneficial for hitchhiker analysis. Overall, the method described herein has proven as a powerful tool for reliable coverage determination of ELISA antibodies, without the need to arbitrarily exclude HCPs during the coverage evaluation.
在与生物制药工艺相关杂质的控制策略中,酶联免疫吸附测定(ELISA)是定量宿主细胞蛋白(HCP)的首选方法。除了二维-免疫印迹(2D-WB),ELISA 抗体的覆盖范围也越来越多地通过基于亲和纯化的液相色谱-串联质谱(AP-MS)方法进行评估。然而,所有这些方法都面临着抗体和基质之间非特异性结合问题,在数据评估过程中涉及任意定义阈值的应用。为了解决这个问题,本研究开发了一种新方法(优化的 AP-MS),其中将可裂解的接头连接到 ELISA 抗体上,从而能够随后分离特异性相互作用的 HCP。通过比较两种方法在方法变异性和假阳性或假阴性命中数量方面的差异,我们可以证明优化的 AP-MS 方法非常具有重现性,并且在识别抗体检测差距方面具有优势,而以前描述的策略存在高估或低估覆盖范围的问题。由于仅鉴定了与抗体相关的 HCP,我们证明该方法有利于搭便车分析。总体而言,本文所述的方法已被证明是一种可靠的 ELISA 抗体覆盖范围确定的有力工具,而无需在覆盖范围评估过程中任意排除 HCP。